Women's Health News: Breaking Women's Health News, Comments and Articles. - Page: 2

11:18 EDT 4th October 2015 | BioPortfolio

Women's Health News - Page: 2Twitter RSS

Read the latest Women's Health News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Women's Health.

Search or Follow Our Women's Health - Page: 2 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Women's Health - Page: 2 News.
You can also follow our Women's Health - Page: 2 news stories on Twitter: @womens_womens

Showing "women breast cancer menopause Pregnancy" News Articles 26 to 50 of 22,000+

Friday 2nd October 2015

UPDATE 2-U.S. FDA expands approval of Merck's Keytruda to lung cancer

Oct 2 (Reuters) - The U.S. Food and Drug Administration on Friday approved Merck & Co Inc's immunotherapy, Keytruda, for patients with advanced non-small cell lung cancer, the most common form of the disease.

Dako, an Agilent Technologies Company, Announces FDA Approval of New Companion Diagnostic for Lung Cancer

Validated Assay Offers New Option for Patients Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, today announced the U.S. Food and Drug Administration (FDA) approval of a new companion diagnostic assay that can reveal whether a patient with advanced non-small cell lung cancer (NSCLC) is likely to respond to a new for...

Incomplete transport policies, payment for risky births in U.S.

(Reuters Health) - U.S. states need better policies for transporting high-risk pregnant women and newborns to the specialized care they need - and then back to their local hospitals for continuing care, researchers say.

FDA Approves KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression On or After Platinum-Containing Chemotherapy

Patients with EGFR or ALK Genomic Tumor Aberrations Should Have Disease Progression on FDA-Approved Therapy for These Aberrations Prior to Receiving KEYTRUDA Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) monotherapy, the compa...

FDA expands approval of Merck's Keytruda to lung cancer

(Reuters) - The U.S. Food and Drug Administration on Friday granted accelerated approval for Merck & Co's immunotherapy, Keytruda, in patients with advanced non-small cell lung cancer, the most common form of the disease.

North Carolina Woman to Begin 30-Day Walk for a Cure for the Disease She’s Conquering 28 Years After Doctors Gave Her Months to Live

Thomasville’s Diane Ramirez, one of the longest-living survivors of a misunderstood and too-often misdiagnosed disease, will embark on a 75-mile, 30-day walk for awareness and a cure to benefit the Pulmonary Hypertension Association Thomasville, NC (PRWEB) October 02, 2015 Thomasville’s Diane Ramirez, one of the longest-living survivors of a misunderstood and too-often misdiagnosed disease, w...

John Elway and Former Mayor Federico Peña Celebrate Grand Opening of ICON’s New Center of Ophthalmology Excellence in Lone Tree

New center is ICON’s third Medicare-approved surgery center, providing state-of-the-art full service medical and surgical eye care services to its surrounding community ICON Eyecare, Colorado’s leader in all laser Cataract and LASIK eye surgery, announced the addition of its new Lone Tree locatio

FDA approves Merck's Keytruda for use in lung cancer

Oct 2 (Reuters) - The U.S. Food and Drug Administration granted accelerated approval for Merck & Co's immunotherapy, Keytruda, in patients with a form of lung cancer.

Allsup Hosts Blog-a-Thon for Breast Cancer

All Things Disability at Blog.Allsup.com features broad range of topics and perspectives during Breast Cancer Awareness Month in October Belleville, Illinois (PRWEB) October 02, 2015 Breast cancer is the most common type of cancer among women in the U.S., and the second-leading cause of cancer-related deaths, according to the Centers for Disease Control and Prevention (CDC). Allsup, a nationwide ...

Sierra Leone: Frontline Nurses In Aftermath of Ebola Outbreak Battle Depression, Stigma and Lack of Recognition

PhotoCredit: Michael Duff | Women in The Survivor Dream ProjectMagdalene is confident as she introduces herself to the group of nineteen survivors. "My name is Magdalene and I am a nurse, I survived Ebola. I caught it from work". She stops there, smi...

Keytruda OK'd for Non-Small Cell Lung Cancer

(MedPage Today) -- For NSCLC not responding to other drugs and expressing PD-L1

$5 Million Gift from Elaine and Kenneth G. Langone Enables NYC's Animal Medical Center To Unveil New Cancer Institute

NEW YORK, Oct. 2, 2015 /PRNewswire/ -- The Animal Medical Center (AMC) in New York City unveiled its new Cancer Institute, made possible through the generosity of AMC Trustee Elaine Langone and her husband Kenneth G. Langone. This revolutionary cancer center, modeled after the most progressive, patient-centered human cancer hospitals, provides an integrative and centralized approach, utilizing the...

Chemists design rapid, simple, inexpensive tests using DNA

Chemists at the University of Montreal are using DNA molecules to develope rapid, inexpensive medical diagnostic tests that take only a few minutes to perform. Their findings, published in the Journal of the American Chemical Society, may aid efforts to build point-of-care devices for quick medical diagnosis of various diseases ranging from cancer, allergies, autoimmune [&hellip The post Chem...

Keytruda approved for PD-L1-expressing NSCLC patients

FDA granted accelerated approval to Keytruda pembrolizumab from Merck & Co. Inc. (NYSE:MRK) to treat advanced squamous and non-squamous non-small cell lung cancer (NSCLC) in previously treated patients, though the label is limited to patients with PD...

Wounded Veterans and Spouses Gather for a Week of Healing and Togetherness at Project Odyssey

KANSAS CITY, Mo., Oct. 2, 2015 /PRNewswire-USNewswire/ -- When returning from combat, many service members find the transition back to civilian life challenging. Often, this challenge takes a toll on their relationships with their spouses, as they struggle to cope with the stress associated with their time in combat. It is with this in mind that Wounded Warrior Project® (WWP) offers its Proje...

Topical BioMedics and The Healthy Back Bag® Company by AmeriBag Offer “Breast Cancer Care Bundle” in Honor of National Breast Cancer Awareness Month

In honor of National Breast Cancer Awareness Month, from October 2nd through October 31st, Topical BioMedics, Inc., and The Healthy Back Bag Company® By Ameribag partner to offer two exclusive “Breast Cancer Care Bundles” at a special reduced price. The bundles include an “I Love My Life” Healthy Back Bag or Baglett and Topricin Foot Therapy Cream to help soothe chemo-induced neuropat...

Upcoming Events: Tesaro Looks For A Second Win And Idera Hopes For Blood Cancer Success

Short, underweight men getting less sex

Chapman University has published research on how many sex partners people have relative to their height and body mass. The study focused on 60,058 heterosexual men and women asking each to indicate their height, weight, and how many sex partner...

The Oncology Nursing Society and Clinical Care Options® Announce Partnership to Provide Innovative Resource for Oncology Nurses

RESTON, Va., Oct. 2, 2015 /PRNewswire-USNewswire/ -- The Oncology Nursing Society (ONS) and Clinical Care Options, LLC (CCO) today announced the creation of a collaborative partnership to support the ongoing development of evidence-based resources. This innovative collaboration will result in a comprehensive self-study online reference and a fully searchable point-of-care decision support res...

Eveo Announces the Launch of Family Reach Give App, First Crowdfunding App for Families Fighting Cancer

SAN FRANCISCO, Oct. 1, 2015 /PRNewswire/ -- Eveo, an award-winning digital healthcare agency, announces the release of its first agency-wide pro-bono project, the Family Reach Give App. 'Give' is the first Crowdfunding app dedicated to providing instant financial relief to families fighting cancer. It allows anyone with a smartphone (iOS and Android) to easily contribute by paying a family's ...

Amoy Enters Diagnostic Collaboration with Illumina

Amoy Diagnostics, a Xiamen maker of in vitro diagnostics, will collaborate with Illumina on Next-Generation Sequencing (NGS) Cancer Diagnostics. Amoy will develop and commercialize a series of oncology-related tests based on Illumina’s NGS plat...

New Compound Derived from Gold and Titanium May Help Combat Kidney Cancer

A special formula made of titanium and gold may be able to combat renal cell carcinoma in a whole new way. In a study published in the journal Chemical Science, researchers report this combination may be more be effective than cisplatin and also associated with little toxicity.

Sea Bags Launches 9th Annual 'Cure Campaign'

Breast Cancer Awareness Collection Available at Seabags.com from October 1 Portland, Maine (PRWEB) October 02, 2015 Sea Bags (http://www.seabags.com), designers and manufacturers of handmade items from recycled sails, will once again sell its popular Breast Cancer Awareness or ‘Cure’ accessories to raise money for breast cancer research. This year represents the company’s ninth year running...

FDA Approves Merck's Keytruda for Lung Cancer

Merck’s Keytruda has received Food and Drug Administration approval for the treatment of non-small cell lung cancer, which accounts for about 85% to 90% of all lung-cancer cases.

Quest Diagnostics Introduces Dako's PD-L1 Companion Diagnostic for KEYTRUDA®, Merck's Anti-PD-1 Therapy for Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression On or After Platinum-Containing Chemotherapy

MADISON, N.J., Oct. 2, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it will provide clinical laboratory testing using the PD-L1 IHC 22C3 PharmDx™ immunohistochemistry companion diagnostic. Earlier today, the U.S. Food and Drug Administration (FDA) approved Merck's KEYTRUDA® (pembrolizumab), an...


News Quicklinks